CRESETTI DRUG CORP NPI 1376546820

NPI Details

CRESETTI DRUG CORP is a pharmacy in Brooklyn, NY. The provider is a facility used by pharmacists for the compounding and dispensing of medicinal preparations and other associated professional and administrative services. A pharmacy is a facility whose primary function is to store, prepare and legally dispense prescription drugs under the professional supervision of a licensed pharmacist. It meets any licensing or certification standards set forth by the jurisdiction where it is located. CRESETTI DRUG CORP NPI is 1376546820. The provider is registered as an organization entity type.

The provider's business location address is:

454 5TH AVE
BROOKLYN, NY
ZIP 11215-003
Phone: (718) 768-0600
Fax: (718) 832-2912

The provider's authorized official is Thomas Christopher Sutherland .
The authorized official title is Pharmacist and has the following contact phone number (718) 768-0600.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count (HCPCS:K1034)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)

The enumeration date for this NPI number is 5/28/2005 and was last updated on 2/27/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.